Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Xavier

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Urology|April 6, 2025
Clinical Performance and Safety for the Rechargeable InterStim Micro System in Non-Obstructive Urinary Retention Subjects: 6-Month Results From the Global Post-Market ELITE StudySachin Malde, Victoria Lavin, Marie-Aimée Perrouin-Verbe, et al.
Neurourology and Urodynamics|March 14, 2023
Evaluation of clinical performance and safety for the rechargeable InterStim Micro device in overactive bladder subjects: 6-month results from the global postmarket ELITE studyColin Goudelocke, Keith Xavier, Barry Pecha, et al.
Neurourology and Urodynamics|July 28, 2022
Prospective, multicenter study to evaluate performance and safety of a re-engineered temporary lead for InterStim™ therapy evaluationDean Elterman, Jodi Michaels, Eric Margolis, et al.
Contemporary Clinical Trials Communications|September 11, 2023
Rationale and design of an implant procedure and pivotal study to evaluate safety and effectiveness of Medtronic's tibial neuromodulation deviceUna J Lee, Keith Xavier, Kevin Benson, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Urology|April 6, 2025
Clinical Performance and Safety for the Rechargeable InterStim Micro System in Non-Obstructive Urinary Retention Subjects: 6-Month Results From the Global Post-Market ELITE StudySachin Malde, Victoria Lavin, Marie-Aimée Perrouin-Verbe, et al.
Neurourology and Urodynamics|March 14, 2023
Evaluation of clinical performance and safety for the rechargeable InterStim Micro device in overactive bladder subjects: 6-month results from the global postmarket ELITE studyColin Goudelocke, Keith Xavier, Barry Pecha, et al.
Neurourology and Urodynamics|July 28, 2022
Prospective, multicenter study to evaluate performance and safety of a re-engineered temporary lead for InterStim™ therapy evaluationDean Elterman, Jodi Michaels, Eric Margolis, et al.
Contemporary Clinical Trials Communications|September 11, 2023
Rationale and design of an implant procedure and pivotal study to evaluate safety and effectiveness of Medtronic's tibial neuromodulation deviceUna J Lee, Keith Xavier, Kevin Benson, et al.
Pageof 2